跳到正文

Aktis Oncology, Inc.(AKTS)内部人交易:高管与董事近期交易

过去 18 个月,共有 21 位内部人为 Aktis Oncology, Inc.(AKTS)报告了 88 笔 Form 4 交易(最近一笔 2026-09-24)。

日期内部人职务类型股数市值
2026-09-24Czibere AkosChief Medical Officer卖出5,099$102,973
2026-09-24Czibere AkosChief Medical Officer买入12,500$61,875
2026-09-24Czibere AkosChief Medical Officer卖出7,401$155,648
2026-07-21Herrmann Ken董事买入3,506$280
2026-07-21Herrmann Ken董事买入1,350$2,578
2026-07-21Herrmann Ken董事卖出3,506$86,115
2026-07-21Herrmann Ken董事卖出1,350$33,159
2026-07-20Herrmann Ken董事买入3,065$245
2026-07-20Herrmann Ken董事卖出3,065$77,259
2026-07-10Ron-Bigger ShulamitChief Operating Officer买入50,000$183,000
2026-07-10Czibere AkosChief Medical Officer买入50,000$247,500
2026-07-10Ron-Bigger ShulamitChief Operating Officer卖出15,800$428,681
2026-07-10Ron-Bigger ShulamitChief Operating Officer卖出30,000$838,137
2026-07-10Czibere AkosChief Medical Officer卖出30,829$861,735
2026-07-10Ron-Bigger ShulamitChief Operating Officer卖出4,200$120,740
2026-07-10Czibere AkosChief Medical Officer卖出4,371$125,482
2026-07-10Czibere AkosChief Medical Officer卖出14,800$401,484
2026-01-14MPM BIOVENTURES 2018 (B), L.P.10% 以上股东买入1.3M$0
2026-01-14EVNIN LUKE10% 以上股东买入1.3M$0
2026-01-14MPM ONCOLOGY INNOVATIONS FUND LP10% 以上股东买入1.3M$0
2026-01-14MPM Oncology Innovations Fund GP LLC10% 以上股东买入1.3M$0
2026-01-14MPM BIOVENTURES 2018, L.P.10% 以上股东买入1.3M$0
2026-01-14MPM ASSET MANAGEMENT INVESTORS BV2018 LLC10% 以上股东买入1.3M$0
2026-01-14MPM BioVentures 2018 GP LLC10% 以上股东买入1.3M$0
2026-01-14MPM BioVentures 2018 LLC10% 以上股东买入1.3M$0

来源:SEC Form 4 申报文件 · 截至 2026-09-24